Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts
- 1 July 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (1), 33-36
- https://doi.org/10.1016/0002-9149(89)90648-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugsThe American Journal of Cardiology, 1988
- Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery diseaseThe American Journal of Cardiology, 1988
- Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome.Circulation, 1987
- Long-term experience with sotalol in the treatment of complex ventricular arrhythmiasAmerican Heart Journal, 1987
- The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography.Circulation, 1987
- Sotalol in patients with Wolff-Parkinson-White syndrome.Circulation, 1987
- Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: Evaluation by programmed stimulation and ambulatory electrocardiogramJournal of the American College of Cardiology, 1986
- Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: A double-blind, randomized, placebo-controlled evaluation of two dosesJournal of the American College of Cardiology, 1986
- Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.Circulation, 1985
- Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.Circulation, 1984